Red wine, dealcoholized red wine, and especially grape juice, inhibit atherosclerosis in a hamster model

Atherosclerosis

Volumn 156, Issue 1, 2001, Pages 67-72

  Vinson, Joe A ^a   Teufel, Karolyn ^a   Wu, Nancy ^a  

^a UNIVERSITY OF SCRANTON   (United States)

Author keywords

Atherosclerosis; Grape juice; Hamster; Lipid peroxidation; Red wine

Indexed keywords

ALCOHOL; POLYPHENOL;

ALCOHOL CONSUMPTION; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; FOAM CELL; FRANCE; FRUIT JUICE; GRAPE; HAMSTER; HYPOLIPEMIA; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; WINE;

ANIMALS; ARTERIOSCLEROSIS; BEVERAGES; CRICETINAE; ETHANOL; MALE; MESOCRICETUS; ROSALES; WINE;

EID: 0035022276     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(00)00625-0     Document Type: Article

References (46)

1. Rimm E.B., Giovannucci E.L., Willett W.C., Colditz G.A., Ascherio A., Rosner B., Stampfer M.J. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet. 339:1991;464-468.
2. Klatsky A.L., Armstrong M.A., Friedman G.D. Alcohol and mortality. Ann Intern Med. 117:1992;646-654.
3. Groenback M., Deis A., Sorenson T.I., Becker U., Borch-Johnsen K., Muller C. Influence of sex, age, body mass index, and smoking on alcohol intake and mortality. Br Med J. 308:1994;302-306.
4. Doll R., Peto R., Hall E., Wheatley K., Gray R. Mortality in relation to consumption of alcohol: 13 years' observations on male British doctors. Br Med J. 309:1994;911-918.
5. Fuchs C.S., Stampfer M.J., Colditz G.A., Giovannucci E.L., Manson J.E., Kawachi I., et al. Alcohol consumption and women. N Engl J Med. 332:1994;1245-1250.
6. St Leger A., Cochrane A.L., Moore F. Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine. Lancet. 1:1979;1017-1020.
7. Nanji A.A. Alcohol and ischemic heart disease: Wine, beer, or both? Int J Cardiol. 8:1985;487-489.
8. Nanji A.A., French S.W. Alcoholic beverages and coronary heart disease. Atherosclerosis. 60:1986;197-198.
9. Hegsted D.M., Ausman L.M. Diet, alcohol and coronary heart disease in men. J Nutr. 118:1988;1184-1189.
10. The WHO MONICA Report. In World Health Statistics Annual. 1989;27-59 World Health Organization, Geneva.
11. Ulbright T.L.V., Southgate D.A.T. Coronary heart disease: seven dietary factors. Lancet. 338:1991;985-992.
12. Criqui M.H., Ringel B.L. Does diet or alcohol explain the French paradox? Lancet. 344:1994;1719-1723.
13. Rosenberg L, Slone D, Shapiro S, Kaufman DW, Miettinen OS, Stolley PD. Alcoholic beverages and myocardial infarction in young women. Am J Public Health 1981;71-5.
14. Gronbaek M., Deis A., Sorensen T.I., Becker U., Schnohr P., Jensen G. Mortality associated with moderate intake of wine, beer or spirits. Br Med J. 310:1995;1165-1169.
15. Criqui H.M. The reduction of coronary heart disease with light to moderate alcohol consumption: effect or artifact? Br J Addict. 85:1990;854-857.
16. Yano K., Rhoads C.G., Kagan A. Coffee, alcohol and risk for coronary heart disease among Japanese men living in Hawaii. N Engl J Med. 297:1977;405-409.
17. Klatsky A.L., Armstrong M.A., Friedman G.D. Relations of alcoholic beverage use to subsequent coronary artery disease hospitalization. Am J Cardiol. 58:1986;710-714.
18. Rimm E.B., Klatsch A., Grobbe D., Stampfer M.J. Review of moderate alcohol consumption and reduced risk of coronary heart disease: Is the effect due to beer, wine, or spirits? Br Med J. 312:1996;731-736.
19. Klurfeld D.M., Kritchevsky D.M. Differential effects of alcoholic beverages on experimental atherosclerosis in rabbits. Exp Mol Pathol. 34:1981;62-71.
20. Hayek T., Fuhrman B., Vaya J., Rosenblat M., Belinky P., Coleman R., et al. Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation. Arterioscler Thromb Vasc Biol. 17:1997;2744-2752.
21. Abbey M., Kerry N.L. Flavonoids and their effects on LDL oxidation. Proc Nutr Soc Australia. 21:1997;91-97.
22. da Luz P.L., Serano J.C.V., Chacra A.P., Monteiro H.P., Yoshida V.M., Furtado M., et al. The effect of red wine on experimental atherosclerois: lipid-independent protection. Exp Mol Pathol. 65:1999;150-159.
23. Frankel E.N., Waterhouse A.L., Teissedre P.L. Principal phenolic phytochemicals in grapes and wines. J Agric Food Chem. 43:1995;890-894.
24. Hertog M.G.L., Feskens E.J.M., Hollman P.C.H., Katan M.B., Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet. 342:1993;1007-1011.
25. Hertog M.G., Kromhout D., Aravanis C., Blackburn H., Buzina R., Fidanza F., et al. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch Intern Med. 155:1995;381-386.
26. Vinson J.A., Dabbagh Y.A., Serry M.M., Jang J. Plant flavonoids, especially tea flavonols, are powerful antioxidants using an in vitro oxidation model for heart disease. J Agric Food Chem. 43:1995;2800-2802.
27. Steinberg D., Parthasarathy S., Carew T.E., Khoo J., Witzum J.L. Beyond cholesterol: modifications of low-density lipoproteins. N Engl J Med. 320:1989;915-924.
28. Serafini M., Maiani G., Ferro-Luzzi A.F. Effect of ethanol on red wine tannin-protein (BSA) interactions. J Agric Food Chem. 45:1997;3148-3151.
29. Arvola A., Forstander O.A. Hamster in experiments of free choice between alcohol and water. Qtrly J Stud Alc. 24:1963;591-597.
30. Kowala M.C., Nunnari J.J., Nicolosi R.J. Doxazosin and cholestyramine similarly decrease fatty streak formation in the aortic arch of hyperlipidemic hamsters. Atherosclerosis. 91:1991;35-49.
31. Stein J.H., Keevil J.G., Wiebe D.A., Aeschlimann S., Folts J.D. Purple grape juice improves endothelial function and reduces the susceptibility of LDL cholesterol to oxidation in patients with coronary artery disease. Circulation. 100:1999;1050-1055.
32. Lepage G., Munoz G., Champagne J., Roy C.C. Preparative steps necessary for the accurate measurement of malondialdehyde by high-performance liquid chromatography. Anal Biochem. 197:1991;277-283.
33. Vinson J.A., Dabbagh Y.A. Effect of green and black tea supplementation on lipids, lipid oxidation and fibrinogen in the hamster: mechanisms for the epidemiological benefits of tea drinking. FEBS Lett. 433:1998;44-46.
34. Morgan A.F., Brinner L., Plaa C.B., Stone M.M. Utilization of calories from alcohol and wines and their effects on cholesterol metabolism. Am J Physiol. 189:1957;290-296.
35. Keung W.-M., Lazo O., Kunze L., Vallee B.L. Daidzin suppresses ethanol consumption by Syrian golden hamsters without blocking acetaldehyde metabolism. Proc Natl Acad Sci USA. 92:1995;8990-8993.
36. Dai J., Miller B.A., Lin R.C. Alcohol feeding impedes early atherosclerosis in low-density lipoprotein receptor knockout mice; factors in addition to high-density lipoprotein-apolipoprotein A1 are involved. Alcohol Clin Exp Res. 21:1997;11-18.
37. Emeson E.E., Manaves V., Singer T., Tabesh M. Chronic alcohol feeding inhibits atherogenesis in C57BL/6 hyperlipidemic mice. Am J Pathol. 147:1995;1749-1758.
38. Yamakoshi J., Kataoka S., Koga T., Ariga T. Proanthocyanidin-rich extract from grape seeds attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits. Atherosclerosis. 142:1999;139-149.
39. Puddey I.B., Croft K. Alcoholic beverages and lipid peroxidation: relevance to cardiovascular disease. Addict Biol. 2:1997;269-276.
40. Trevithick C.C., Vinson J.A., Caulfeild J., Rahman F., Derksen T., Bocksch L., et al. Is ethanol an important antioxidant in alcoholic beverages associated with risk reduction of cataract and atherosclerosis? Redox Rep. 4:1999;89-93.
41. Mosca L., Rubenfire M., Tarshis T., Tsai A., Pearson T. Clinical predictors of oxidized low- density lipoprotein in patients with coronary artery disease. Am J Cardiol. 90:1997;825-830.
42. Vinson J.A., Jang J., Dabbagh A., Serry M.M., Cai S. Plant polyphenols exhibit lipoprotein- bound antioxidant activity using an in vitro oxidation model for heart disease. J Agric Food Chem. 43:1995;2798-2799.
43. Vinson J.A., Jang J., Yang J., Dabbagh Y., Liang X., Serry M., et al. Vitamins and especially flavonoids in common beverages are powerful in vitro antioxidants which enrich lower density lipoproteins and increase their oxidative resistance after ex vivo spiking in human plasma. J Agric Food Chem. 47:1999;2502-2504.
44. Schwenke D.C., Behr S.R. Vitamin E combined with selenium inhibits atherosclerosis in hypercholesterolemic rabbits independently of effects on plasma cholesterol concentrations. Circ Res. 83:1998;366-377.
45. Wollny T., Aiello L., Di Tommaso D., Bellavia V., Rotilio D., Donati M.B., de Gaetano G., Iacoviello L. Modulation of haemostatic function and prevention of experimental thrombosis by red wine in rats: a role for increased nitric oxide production. Br J Pharmacol. 127:1999;747-755.
46. Bell J.R., Donovan J.L., Wong R., Waterhouse A.L., German J.B., Walzem R.L., Kasim-Karakas S.E. (+)-Catechin in human plasma after ingestion of a single serving of reconstituted red wine. Am J Clin Nutr. 71:2000;103-108.